Intrinsic Disorder in the Androgen Receptor

Identification, Characterisation and Drugability

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The androgen receptor (AR) regulates networks of genes in response to the steroid hormones testosterone and dihydrotestosterone. The receptor protein is made up of both stably folded globular domains, involved in hormone and DNA binding, and regions of intrinsic disorder, including the N-terminal domain (NTD). The AR-NTD has a modular activation function (termed AF1) and is important for gene regulation, participating in multiple protein-protein interactions. Biophysical studies have revealed that AR-NTD/AF1 has limited stable secondary structure and conforms to a ‘collapsed disordered’ conformation. The AR-NTD/AF1 has the propensity to adopt an ¿-helical conformation in response to a natural osmolyte or a co-regulatory binding partner. The AR is a key drug target in the management of advanced prostate cancer and recently a small molecule inhibitor was identified that interacts with the NTD/AF1 and impairs protein-protein interactions and recruitment of the receptor to target genes. In this review the role of intrinsic disorder in AR function is discussed along with the potential to develop new drugs that will target the structurally plastic NTD.
Original languageEnglish
Pages (from-to)82-90
Number of pages9
JournalMolecular BioSystems
Volume8
Issue number1
Early online date5 Aug 2011
DOIs
Publication statusPublished - 2012

Fingerprint

Androgen Receptors
Proteins
Hormones
Dihydrotestosterone
Gene Regulatory Networks
Pharmaceutical Preparations
Genes
Plastics
Testosterone
Prostatic Neoplasms
Steroids
DNA

Cite this

Intrinsic Disorder in the Androgen Receptor : Identification, Characterisation and Drugability. / McEwan, Iain Joseph.

In: Molecular BioSystems, Vol. 8, No. 1, 2012, p. 82-90.

Research output: Contribution to journalArticle

@article{0dbd33dfb31c48e29bcbf68a969dc25a,
title = "Intrinsic Disorder in the Androgen Receptor: Identification, Characterisation and Drugability",
abstract = "The androgen receptor (AR) regulates networks of genes in response to the steroid hormones testosterone and dihydrotestosterone. The receptor protein is made up of both stably folded globular domains, involved in hormone and DNA binding, and regions of intrinsic disorder, including the N-terminal domain (NTD). The AR-NTD has a modular activation function (termed AF1) and is important for gene regulation, participating in multiple protein-protein interactions. Biophysical studies have revealed that AR-NTD/AF1 has limited stable secondary structure and conforms to a ‘collapsed disordered’ conformation. The AR-NTD/AF1 has the propensity to adopt an ¿-helical conformation in response to a natural osmolyte or a co-regulatory binding partner. The AR is a key drug target in the management of advanced prostate cancer and recently a small molecule inhibitor was identified that interacts with the NTD/AF1 and impairs protein-protein interactions and recruitment of the receptor to target genes. In this review the role of intrinsic disorder in AR function is discussed along with the potential to develop new drugs that will target the structurally plastic NTD.",
author = "McEwan, {Iain Joseph}",
year = "2012",
doi = "10.1039/c1mb05249g",
language = "English",
volume = "8",
pages = "82--90",
journal = "Molecular BioSystems",
issn = "1742-206X",
publisher = "Royal Society of Chemistry",
number = "1",

}

TY - JOUR

T1 - Intrinsic Disorder in the Androgen Receptor

T2 - Identification, Characterisation and Drugability

AU - McEwan, Iain Joseph

PY - 2012

Y1 - 2012

N2 - The androgen receptor (AR) regulates networks of genes in response to the steroid hormones testosterone and dihydrotestosterone. The receptor protein is made up of both stably folded globular domains, involved in hormone and DNA binding, and regions of intrinsic disorder, including the N-terminal domain (NTD). The AR-NTD has a modular activation function (termed AF1) and is important for gene regulation, participating in multiple protein-protein interactions. Biophysical studies have revealed that AR-NTD/AF1 has limited stable secondary structure and conforms to a ‘collapsed disordered’ conformation. The AR-NTD/AF1 has the propensity to adopt an ¿-helical conformation in response to a natural osmolyte or a co-regulatory binding partner. The AR is a key drug target in the management of advanced prostate cancer and recently a small molecule inhibitor was identified that interacts with the NTD/AF1 and impairs protein-protein interactions and recruitment of the receptor to target genes. In this review the role of intrinsic disorder in AR function is discussed along with the potential to develop new drugs that will target the structurally plastic NTD.

AB - The androgen receptor (AR) regulates networks of genes in response to the steroid hormones testosterone and dihydrotestosterone. The receptor protein is made up of both stably folded globular domains, involved in hormone and DNA binding, and regions of intrinsic disorder, including the N-terminal domain (NTD). The AR-NTD has a modular activation function (termed AF1) and is important for gene regulation, participating in multiple protein-protein interactions. Biophysical studies have revealed that AR-NTD/AF1 has limited stable secondary structure and conforms to a ‘collapsed disordered’ conformation. The AR-NTD/AF1 has the propensity to adopt an ¿-helical conformation in response to a natural osmolyte or a co-regulatory binding partner. The AR is a key drug target in the management of advanced prostate cancer and recently a small molecule inhibitor was identified that interacts with the NTD/AF1 and impairs protein-protein interactions and recruitment of the receptor to target genes. In this review the role of intrinsic disorder in AR function is discussed along with the potential to develop new drugs that will target the structurally plastic NTD.

U2 - 10.1039/c1mb05249g

DO - 10.1039/c1mb05249g

M3 - Article

VL - 8

SP - 82

EP - 90

JO - Molecular BioSystems

JF - Molecular BioSystems

SN - 1742-206X

IS - 1

ER -